CLOMIPHENE CITRATE Drug Patent Profile
✉ Email this page to a colleague
When do Clomiphene Citrate patents expire, and what generic alternatives are available?
Clomiphene Citrate is a drug marketed by Cosette and is included in one NDA.
The generic ingredient in CLOMIPHENE CITRATE is clomiphene citrate. There are sixteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the clomiphene citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clomiphene Citrate
A generic version of CLOMIPHENE CITRATE was approved as clomiphene citrate by COSETTE on August 30th, 1999.
Summary for CLOMIPHENE CITRATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 166 |
Clinical Trials: | 170 |
Patent Applications: | 562 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CLOMIPHENE CITRATE |
What excipients (inactive ingredients) are in CLOMIPHENE CITRATE? | CLOMIPHENE CITRATE excipients list |
DailyMed Link: | CLOMIPHENE CITRATE at DailyMed |
Recent Clinical Trials for CLOMIPHENE CITRATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Bezmialem Vakif University | N/A |
University of Chicago | Phase 3 |
Johns Hopkins University | Phase 3 |
Pharmacology for CLOMIPHENE CITRATE
Drug Class | Estrogen Agonist/Antagonist |
Mechanism of Action | Selective Estrogen Receptor Modulators |
Medical Subject Heading (MeSH) Categories for CLOMIPHENE CITRATE
US Patents and Regulatory Information for CLOMIPHENE CITRATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cosette | CLOMIPHENE CITRATE | clomiphene citrate | TABLET;ORAL | 075528-001 | Aug 30, 1999 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |